ABOUT ABBOTT
International | eng
Country Language
Abbott logo

AFIBLife App References

These references and sources are used on the AFibLife™ app.


References

  1. CDC. Atrial Fibrillation Fact Sheet. https:\\www.cdc.gov\heartdisease/atrial_fibrillation.htm, 8 Sept. 2020. Accessed 19 Sept. 2020.
  2. Calkins H, Reynolds MR, Spector P et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythmia Electrophysiol. 2009; 2:349–361.
  3. Odutayo A, Wong CX, Hsiao AJ et al. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016; 354:i4482.

MAT-2307771 v1.0

 

Abbott Logo

Illustrations are artist's representations only and should not be considered as engineering drawings or photographs.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company. ™ Indicates a trademark of the Abbott group of companies. ‡ Indicates a third party trademark, which is property of its respective owner.

© 2024 Abbott. All Rights Reserved.

MAT-2102398 v6.0

Disclaimer

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

MAT-2108924 v2.0 | Item approved for use outside of the United States only.